Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1959 2
1961 1
1962 1
1963 6
1964 3
1965 1
1966 1
1967 2
1968 2
1969 1
1971 1
1972 2
1973 3
1974 2
1975 4
1976 1
1978 1
1980 1
1981 2
1982 3
1983 7
1984 3
1985 3
1986 7
1987 7
1988 6
1989 5
1990 7
1991 10
1992 5
1993 6
1994 5
1995 10
1996 7
1997 8
1998 13
1999 9
2000 13
2001 6
2002 6
2003 8
2004 9
2005 15
2006 3
2007 14
2008 16
2009 12
2010 21
2011 22
2012 17
2013 27
2014 39
2015 50
2016 37
2017 32
2018 31
2019 18
2020 25
2021 34
2022 35
2023 13
Text availability
Article attribute
Article type
Publication date

Search Results

578 results
Results by year
Filters applied: . Clear all
Page 1
Sunitinib Alone or after Nephrectomy in Metastatic Renal-Cell Carcinoma.
Méjean A, Ravaud A, Thezenas S, Colas S, Beauval JB, Bensalah K, Geoffrois L, Thiery-Vuillemin A, Cormier L, Lang H, Guy L, Gravis G, Rolland F, Linassier C, Lechevallier E, Beisland C, Aitchison M, Oudard S, Patard JJ, Theodore C, Chevreau C, Laguerre B, Hubert J, Gross-Goupil M, Bernhard JC, Albiges L, Timsit MO, Lebret T, Escudier B. Méjean A, et al. Among authors: bernhard jc. N Engl J Med. 2018 Aug 2;379(5):417-427. doi: 10.1056/NEJMoa1803675. Epub 2018 Jun 3. N Engl J Med. 2018. PMID: 29860937 Free article. Clinical Trial.
Adjuvant exemestane with ovarian suppression in premenopausal breast cancer.
Pagani O, Regan MM, Walley BA, Fleming GF, Colleoni M, Láng I, Gomez HL, Tondini C, Burstein HJ, Perez EA, Ciruelos E, Stearns V, Bonnefoi HR, Martino S, Geyer CE Jr, Pinotti G, Puglisi F, Crivellari D, Ruhstaller T, Winer EP, Rabaglio-Poretti M, Maibach R, Ruepp B, Giobbie-Hurder A, Price KN, Bernhard J, Luo W, Ribi K, Viale G, Coates AS, Gelber RD, Goldhirsch A, Francis PA; TEXT and SOFT Investigators; International Breast Cancer Study Group. Pagani O, et al. Among authors: bernhard j. N Engl J Med. 2014 Jul 10;371(2):107-18. doi: 10.1056/NEJMoa1404037. Epub 2014 Jun 1. N Engl J Med. 2014. PMID: 24881463 Free PMC article. Clinical Trial.
Sunitinib Alone or After Nephrectomy for Patients with Metastatic Renal Cell Carcinoma: Is There Still a Role for Cytoreductive Nephrectomy?
Méjean A, Ravaud A, Thezenas S, Chevreau C, Bensalah K, Geoffrois L, Thiery-Vuillemin A, Cormier L, Lang H, Guy L, Gravis G, Rolland F, Linassier C, Lechevallier E, Oudard S, Laguerre B, Gross-Goupil M, Bernhard JC, Colas S, Albiges L, Lebret T, Treluyer JM, Timsit MO, Escudier B. Méjean A, et al. Among authors: bernhard jc. Eur Urol. 2021 Oct;80(4):417-424. doi: 10.1016/j.eururo.2021.06.009. Epub 2021 Jun 27. Eur Urol. 2021. PMID: 34187771
Nivolumab, nivolumab-ipilimumab, and VEGFR-tyrosine kinase inhibitors as first-line treatment for metastatic clear-cell renal cell carcinoma (BIONIKK): a biomarker-driven, open-label, non-comparative, randomised, phase 2 trial.
Vano YA, Elaidi R, Bennamoun M, Chevreau C, Borchiellini D, Pannier D, Maillet D, Gross-Goupil M, Tournigand C, Laguerre B, Barthélémy P, Coquan E, Gravis G, Houede N, Cancel M, Huillard O, Beuzeboc P, Fournier L, Méjean A, Cathelineau X, Doumerc N, Paparel P, Bernhard JC, de la Taille A, Bensalah K, Tricard T, Waeckel T, Pignot G, Braychenko E, Caruso S, Sun CM, Verkarre V, Lacroix G, Moreira M, Meylan M, Bougouïn A, Phan L, Thibault-Carpentier C, Zucman-Rossi J, Fridman WH, Sautès-Fridman C, Oudard S. Vano YA, et al. Among authors: bernhard jc. Lancet Oncol. 2022 May;23(5):612-624. doi: 10.1016/S1470-2045(22)00128-0. Epub 2022 Apr 4. Lancet Oncol. 2022. PMID: 35390339 Clinical Trial.
Dose-intensified Versus Conventional-dose Salvage Radiotherapy for Biochemically Recurrent Prostate Cancer After Prostatectomy: The SAKK 09/10 Randomized Phase 3 Trial.
Ghadjar P, Hayoz S, Bernhard J, Zwahlen DR, Hölscher T, Gut P, Polat B, Hildebrandt G, Müller AC, Plasswilm L, Papachristofilou A, Schär C, Sumila M, Zaugg K, Guckenberger M, Ost P, Reuter C, Bosetti DG, Khanfir K, Gomez S, Wust P, Thalmann GN, Aebersold DM; Swiss Group for Clinical Cancer Research (SAKK). Ghadjar P, et al. Among authors: bernhard j. Eur Urol. 2021 Sep;80(3):306-315. doi: 10.1016/j.eururo.2021.05.033. Epub 2021 Jun 14. Eur Urol. 2021. PMID: 34140144 Clinical Trial.
Experimental and computational modeling for signature and biomarker discovery of renal cell carcinoma progression.
Cooley LS, Rudewicz J, Souleyreau W, Emanuelli A, Alvarez-Arenas A, Clarke K, Falciani F, Dufies M, Lambrechts D, Modave E, Chalopin-Fillot D, Pineau R, Ambrosetti D, Bernhard JC, Ravaud A, Négrier S, Ferrero JM, Pagès G, Benzekry S, Nikolski M, Bikfalvi A. Cooley LS, et al. Among authors: bernhard jc. Mol Cancer. 2021 Oct 20;20(1):136. doi: 10.1186/s12943-021-01416-5. Mol Cancer. 2021. PMID: 34670568 Free PMC article.
Mastocytosis.
Golkar L, Bernhard JD. Golkar L, et al. Among authors: bernhard jd. Lancet. 1997 May 10;349(9062):1379-85. doi: 10.1016/S0140-6736(96)07056-0. Lancet. 1997. PMID: 9149712 Review. No abstract available.
Néphrectomie partielle robot-assistée sans clampage : est-ce vraiment utile ?
Peyronnet B, Pradere B, Khene Z, Masson-Lecomte A, Roumiguié M, Beauval J, Droupy S, De la Taille A, Baumert H, Doumerc N, Bernhard J, Vaessen C, Bruyère F, Bensalah K. Peyronnet B, et al. Among authors: bernhard j. Prog Urol. 2015 Nov;25(13):823. doi: 10.1016/j.purol.2015.08.214. Prog Urol. 2015. PMID: 26544409 French. No abstract available.
578 results